{"protocolSection":{"identificationModule":{"nctId":"NCT00229177","orgStudyIdInfo":{"id":"ONO-2506-08"},"organization":{"fullName":"Ono Pharmaceutical Co. Ltd","class":"INDUSTRY"},"briefTitle":"Study of ONO-2506 in Patients With Acute Ischemic Stroke","officialTitle":"Controlled Study of ONO-2506 in Patients With Acute Ischemic Stroke"},"statusModule":{"statusVerifiedDate":"2012-06","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2005-09"},"primaryCompletionDateStruct":{"date":"2008-09","type":"ACTUAL"},"completionDateStruct":{"date":"2008-09","type":"ACTUAL"},"studyFirstSubmitDate":"2005-09-27","studyFirstSubmitQcDate":"2005-09-27","studyFirstPostDateStruct":{"date":"2005-09-29","type":"ESTIMATED"},"lastUpdateSubmitDate":"2012-06-12","lastUpdatePostDateStruct":{"date":"2012-06-13","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Ono Pharmaceutical Co. Ltd","class":"INDUSTRY"}},"descriptionModule":{"briefSummary":"The purpose of this study is to determine the efficacy and safety of ONO-2506 compared to placebo in patients with acute ischemic stroke."},"conditionsModule":{"conditions":["Stroke"],"keywords":["ONO-2506","stroke","Acute ischemic stroke"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE2","PHASE3"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"QUADRUPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":757,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"P","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: ONO-2506"]},{"label":"E1","type":"EXPERIMENTAL","interventionNames":["Drug: ONO-2506"]},{"label":"E2","type":"EXPERIMENTAL","interventionNames":["Drug: ONO-2506"]}],"interventions":[{"type":"DRUG","name":"ONO-2506","description":"Once daily one-hour intravenous infusion at 12/mg/kg/hr for 7 days","armGroupLabels":["E2"]},{"type":"DRUG","name":"ONO-2506","description":"Once daily one-hour intravenous infusion at 0 mg/kg/hr for 7 days","armGroupLabels":["P"]},{"type":"DRUG","name":"ONO-2506","description":"Once daily one-hour intravenous infusion at 8 mg/kg/hr for 7 days","armGroupLabels":["E1"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Modified Rankin Scale at 90 days","timeFrame":"90 days"}],"secondaryOutcomes":[{"measure":"Modified Rankin Scale at 30 days","timeFrame":"30 days"},{"measure":"National Institutes of Health Stroke Scale (NIHSS), Barthel Index (BI), and Glasgow Outcome Scale (GOS) at 90 days","timeFrame":"90 days"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Subjects who have a clinical diagnosis of acute ischemic stroke\n2. Subjects within 72 hours after onset of the stroke\n3. Other inclusion criteria may apply.\n\nExclusion Criteria:\n\n1. Subjects who are scheduled to have surgical operations likely to affect the prognosis (including intravascular surgery and circulatory reconstruction)\n2. Subjects who are pregnant or lactating, or who have child-bearing potential, or who wish to become pregnant.\n3. Other exclusion criteria may apply.","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","maximumAge":"79 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Project Leader, Development Planning","affiliation":"Ono Pharmaceutical Co. Ltd","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"Chubu Region Facility","city":"Chubu","country":"Japan","geoPoint":{"lat":35.43379,"lon":140.2797}},{"facility":"Chugoku Region Facility","city":"Chugoku","country":"Japan"},{"facility":"Hokkaido Region Facility","city":"Hokkaido","country":"Japan","geoPoint":{"lat":43.41104,"lon":142.88878}},{"facility":"Hokuriku Region Facility","city":"Hokuriku","country":"Japan"},{"facility":"Kanto Region Facility","city":"Kanto","country":"Japan"},{"facility":"Kinki Region Facility","city":"Kinki","country":"Japan"},{"facility":"Kyushu Region Facility","city":"Kyushu","country":"Japan"},{"facility":"Shikoku Region Facility","city":"Shikoku","country":"Japan"},{"facility":"Tohoku Region Facility","city":"Tohuku","country":"Japan"}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}